Erin F. DiMauro, Ph.D.

Affiliations: 
2003 University of Pennsylvania, Philadelphia, PA, United States 
Area:
asymmetric catalysts
Google:
"Erin DiMauro"
Mean distance: 9.11
 
SNBCP

Parents

Sign in to add mentor
Marisa C. Kozlowski grad student 2003 Penn
 (Development of bifunctional salen catalysts with modular ligand motifs for asymmetric synthesis.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Boezio AA, Andrews K, Boezio C, et al. (2018) 1,2,4-Triazolsulfone: A novel isosteric replacement of acylsulfonamides in the context of Na1.7 inhibition. Bioorganic & Medicinal Chemistry Letters
Sparling BA, DiMauro EF. (2017) Progress in the discovery of small molecule modulators of the Cys-loop superfamily receptors. Bioorganic & Medicinal Chemistry Letters
Graceffa RF, Boezio AA, Able J, et al. (2017) Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency, Pharmacokinetics, and Metabolic Properties to Obtain Atropisomeric Quinolinone (AM-0466) that Affords Robust In Vivo Activity. Journal of Medicinal Chemistry
Weiss MM, Dineen TA, Marx IE, et al. (2017) Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities. Journal of Medicinal Chemistry
DiMauro EF, Altmann S, Berry LM, et al. (2016) Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective NaV1.7 Inhibitors. Journal of Medicinal Chemistry
Huang H, Guzman-Perez A, Acquaviva L, et al. (2013) Structure-based design of 2-aminopyridine oxazolidinones as potent and selective tankyrase inhibitors. Acs Medicinal Chemistry Letters. 4: 1218-23
Hua Z, Bregman H, Buchanan JL, et al. (2013) Development of novel dual binders as potent, selective, and orally bioavailable tankyrase inhibitors. Journal of Medicinal Chemistry. 56: 10003-15
Bregman H, Chakka N, Guzman-Perez A, et al. (2013) Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors. Journal of Medicinal Chemistry. 56: 4320-42
Bregman H, Gunaydin H, Gu Y, et al. (2013) Discovery of a class of novel tankyrase inhibitors that bind to both the nicotinamide pocket and the induced pocket. Journal of Medicinal Chemistry. 56: 1341-5
Huang H, Acquaviva L, Berry V, et al. (2012) Structure-Based Design of Potent and Selective CK1γ Inhibitors. Acs Medicinal Chemistry Letters. 3: 1059-64
See more...